BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42 Suppl:S100-S107. [PMID: 15777564 DOI: 10.1016/j.jhep.2004.11.015] [Cited by in Crossref: 316] [Cited by in F6Publishing: 283] [Article Influence: 17.6] [Reference Citation Analysis]
Number Citing Articles
1 Camilla R, Magnetti F, Barbera C, Bignamini E, Riggi C, Coppo R; On behalf of the core group of the Children with Chronic Organ disease Network. Children with chronic organ failure possibly ending in organ transplantation: a survey in an Italian region of 5 000 000 inhabitants. Acta Paediatrica 2008;97:1285-91. [DOI: 10.1111/j.1651-2227.2008.00854.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Cholongitas E, Marelli L, Kerry A, Goodier DW, Nair D, Thomas M, Patch D, Burroughs AK. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant. 2007;7:685-692. [PMID: 17217437 DOI: 10.1111/j.1600-6143.2007.01666.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 6.0] [Reference Citation Analysis]
3 Wang J, Zhang Z, Yan X, Li M, Xia J, Liu Y, Chen Y, Jia B, Zhu L, Zhu C, Huang R, Wu C. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis. Digestive and Liver Disease 2019;51:1172-8. [DOI: 10.1016/j.dld.2019.01.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
4 Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-vallée J, Duvoux C, Lerut J, Le Treut Y, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F. Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score-based liver allocation system: Meld Exceptions in the French System. Liver Transpl 2011;17:1137-51. [DOI: 10.1002/lt.22363] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
5 Grosso G, di Francesco F, Vizzini G, Mistretta A, Pagano D, Echeverri GJ, Spada M, Basile F, Gridelli B, Gruttadauria S. The Charlson comorbidity index as a predictor of outcomes in liver transplantation: single-center experience. Transplant Proc. 2012;44:1298-1302. [PMID: 22664004 DOI: 10.1016/j.transproceed.2012.01.131] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
6 Li H, Chen TW, Li ZL, Zhang XM, Li CJ, Chen XL, Chen GW, Hu JN, Ye YQ. Albumin and magnetic resonance imaging-liver volume to identify hepatitis B-related cirrhosis and esophageal varices. World J Gastroenterol 2015; 21(3): 988-996 [PMID: 25624735 DOI: 10.3748/wjg.v21.i3.988] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
7 Al-dury S, Waern J, Waldenström J, Alavanja M, Saed HH, Törnell A, Arabpour M, Wiktorin HG, Einarsdottir S, Ringlander J, Ringström G, Hellstrand K, Martner A, Lagging M. Impaired SARS-CoV-2-specific T cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100496] [Reference Citation Analysis]
8 Zheng MH, Shi KQ, Lin XF, Xiao DD, Chen LL, Liu WY, Fan YC, Chen YP. A model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using artificial neural network. J Viral Hepat 2013;20:248-55. [PMID: 23490369 DOI: 10.1111/j.1365-2893.2012.01647.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
9 García-Bañuelos J, Panduro A, Gordillo-Bastidas D, Gordillo-Bastidas E, Muñoz-Valle JF, Gurrola-Díaz CM, Sánchez-Enríquez S, Ruiz-Madrigal B, Bastidas-Ramírez BE. Genetic polymorphisms of genes coding to alcohol-metabolizing enzymes in western Mexicans: association of CYP2E1*c2/CYP2E1*5B allele with cirrhosis and liver function. Alcohol Clin Exp Res 2012;36:425-31. [PMID: 21895718 DOI: 10.1111/j.1530-0277.2011.01617.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
10 Torp N, Israelsen M, Madsen B, Lutz P, Jansen C, Strassburg C, Mortensen C, Knudsen AW, Sorensen GL, Holmskov U, Schlosser A, Thiele M, Trebicka J, Krag A. Corrigendum to 'Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis' [JHEP Reports 3 (2021) 100287]. JHEP Rep 2021;3:100353. [PMID: 34693237 DOI: 10.1016/j.jhepr.2021.100353] [Reference Citation Analysis]
11 Liu S, Miao J, Shi X, Wu Y, Jiang C, Zhu X, Wu X, Ding Y, Xu Q. Risk Factors for Post-Transplant Death in Donation after Circulatory Death Liver Transplantation. J Invest Surg 2018;31:393-401. [PMID: 28829664 DOI: 10.1080/08941939.2017.1339152] [Reference Citation Analysis]
12 Shah M, Patnaik S, Maludum O, Patil S, De Venecia TA, Figueredo VM. Echocardiographic and Electrocardiographic Predictors of Adverse Outcomes in Spontaneous Bacterial Peritonitis. J Clin Exp Hepatol 2017;7:321-7. [PMID: 29234197 DOI: 10.1016/j.jceh.2017.05.007] [Reference Citation Analysis]
13 Liao W, Ma G, Su Q, Fang Y, Gu B, Zou X. Dexmedetomidine versus Midazolam for Conscious Sedation in Postoperative Patients Undergoing Flexible Bronchoscopy: A Randomized Study. J Int Med Res 2012;40:1371-80. [DOI: 10.1177/147323001204000415] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
14 Božin T, Mustapić S, Bokun T, Patrlj L, Rakić M, Aralica G, Kujundžić M, Trkulja V, Grgurević I. Albi Score as a Predictor of Survival in Patients with Compensated Cirrhosis Resected for Hepatocellular Carcinoma: Exploratory Evaluation in Relationship to Palbi and Meld Liver Function Scores. Acta Clin Croat 2018;57:292-300. [PMID: 30431722 DOI: 10.20471/acc.2018.57.02.09] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK. Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 2005;22:1079-89. [PMID: 16305721 DOI: 10.1111/j.1365-2036.2005.02691.x] [Cited by in Crossref: 221] [Cited by in F6Publishing: 213] [Article Influence: 13.8] [Reference Citation Analysis]
16 Muilenburg DJ, Singh A, Torzilli G, Khatri VP. Surgery in the Patient with Liver Disease. Medical Clinics of North America 2009;93:1065-81. [DOI: 10.1016/j.mcna.2009.05.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
17 Huo TI, Huang YH, Lin HC, Wu JC, Chiang JH, Lee PC, Chang FY, Lee SD. Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy. Am J Gastroenterol. 2006;101:975-982. [PMID: 16573785 DOI: 10.1111/j.1572-0241.2006.00462.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
18 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231. [PMID: 16298014 DOI: 10.1016/j.jhep.2005.10.013] [Cited by in Crossref: 1547] [Cited by in F6Publishing: 1305] [Article Influence: 91.0] [Reference Citation Analysis]
19 Torp N, Israelsen M, Madsen B, Lutz P, Jansen C, Strassburg C, Mortensen C, Knudsen AW, Sorensen GL, Holmskov U, Schlosser A, Thiele M, Trebicka J, Krag A. Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis. JHEP Rep 2021;3:100287. [PMID: 34041469 DOI: 10.1016/j.jhepr.2021.100287] [Reference Citation Analysis]
20 Haliloglu N, Ozkavukcu E, Erden A. Are caudate-right lobe ratio and splenic size correlated with the MELD score in cirrhotic patients? Clin Imaging 2013;37:526-9. [PMID: 23102931 DOI: 10.1016/j.clinimag.2012.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Dangleben DA, Jazaeri O, Wasser T, Cipolle M, Pasquale M. Impact of cirrhosis on outcomes in trauma. J Am Coll Surg. 2006;203:908-913. [PMID: 17116560 DOI: 10.1016/j.jamcollsurg.2006.08.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
22 Ghaferi AA, Mathur AK, Sonnenday CJ, Dimick JB. Adverse Outcomes in Patients With Chronic Liver Disease Undergoing Colorectal Surgery. Annals of Surgery 2010;252:345-50. [DOI: 10.1097/sla.0b013e3181e982d6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
23 Pei Y, Chai S, Zhang Y, Zhang Z, Chen X, Zhang W. Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study. J Gastrointest Surg 2019;23:2151-62. [PMID: 30511133 DOI: 10.1007/s11605-018-3981-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Chernousov AF, Khorobrykh TV, Karpova RV. [Liver tissue regeneration under the influence of cryoprecipitate and alloplant]. Khirurgiia (Mosk) 2015;:27-33. [PMID: 26271561 DOI: 10.17116/hirurgia2015727-33] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Cortez AP, de Morais MB, Speridião Pda G, da Motta Mattar RH, Calanca F, Neto UF. Food intake, growth and body composition of children and adolescents with autoimmune hepatitis. J Clin Gastroenterol 2010;44:200-7. [PMID: 19826277 DOI: 10.1097/MCG.0b013e3181b9145a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Vaz J, Strömberg U, Eriksson B, Buchebner D, Midlöv P. Socioeconomic and marital status among liver cirrhosis patients and associations with mortality: a population-based cohort study in Sweden. BMC Public Health 2020;20:1820. [PMID: 33256682 DOI: 10.1186/s12889-020-09783-2] [Reference Citation Analysis]
27 Fukushima H, Nishio K, Asai H, Watanabe T, Seki T, Matsui H, Sugimoto M, Matsumoto M, Fujimura Y, Okuchi K. Ratio of von Willebrand Factor Propeptide to ADAMTS13 Is Associated With Severity of Sepsis. Shock 2013;39:409-14. [DOI: 10.1097/shk.0b013e3182908ea7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
28 Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol. 2012;57:203-212. [PMID: 22446690 DOI: 10.1016/j.jhep.2011.12.034] [Cited by in Crossref: 133] [Cited by in F6Publishing: 109] [Article Influence: 13.3] [Reference Citation Analysis]
29 Schouten J, Francque S, Van Vlierberghe H, Colle I, Nevens F, Delwaide J, Adler M, Starkel P, Ysebaert D, Gadisseur A, De Winter B, Smits J, Rahmel A, Michielsen P. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth: Laboratory-induced differences in MELD score. Clinical Transplantation 2012;26:E62-70. [DOI: 10.1111/j.1399-0012.2011.01538.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
30 Elmeliegy M, Yang DZ, Salama E, Parivar K, Wang DD. Discordance Between Child-Pugh and National Cancer Institute Classifications for Hepatic Dysfunction: Implications on Dosing Recommendations for Oncology Compounds. J Clin Pharmacol 2021;61:105-15. [PMID: 32691438 DOI: 10.1002/jcph.1702] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
31 Legaz I, Bolarin JM, Campillo JA, Moya RM, Luna A, Osuna E, Minguela A, Sanchez-Bueno F, Alvarez MR, Muro M. Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease. Arch Med Sci 2021;17:682-93. [PMID: 34025838 DOI: 10.5114/aoms.2018.80651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Augusto VS, Castro E Silva O, Souza ME, Sankarankutty AK. Evaluation of the respiratory muscle strength of cirrhotic patients: relationship with Child-Turcotte-Pugh scoring system. Transplant Proc. 2008;40:774-776. [PMID: 18455013 DOI: 10.1016/j.transproceed.2008.03.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine (Baltimore) 2017;96:e7142. [PMID: 28614241 DOI: 10.1097/MD.0000000000007142] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 5.2] [Reference Citation Analysis]
34 Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824-828, discussion 828. [PMID: 16327492 DOI: 10.1097/01.sla.0000189131.90876.9e] [Cited by in Crossref: 658] [Cited by in F6Publishing: 615] [Article Influence: 41.1] [Reference Citation Analysis]
35 Pereira Guedes T, Fragoso P, Lemos C, Garrido M, Silva J, Falcão D, Maia L, Moreira T, Manuel Ferreira J, Pedroto I. Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort. GE Port J Gastroenterol 2020;27:149-59. [PMID: 32509920 DOI: 10.1159/000503074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Salani F, Latarani M, Casadei-Gardini A, Gangadharannambiar P, Fornaro L, Vivaldi C, Pecora I, Massa V, Marisi G, Canale M, Ulivi P, Scartozzi M, Eccleston M, Masi G, Crea F. Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib. Epigenomics 2022. [PMID: 35473355 DOI: 10.2217/epi-2021-0383] [Reference Citation Analysis]
37 Gorospe FF, Istanboulian L, Puts M, Wong D, Lee E, Dale CM. A scoping review to identify and map the multidimensional domains of pain in adults with advanced liver disease. Can J Pain 2020;4:210-24. [PMID: 33987500 DOI: 10.1080/24740527.2020.1785855] [Reference Citation Analysis]
38 Weersink RA, Burger DM, Hayward KL, Taxis K, Drenth JP, Borgsteede SD. Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations. Expert Opinion on Drug Metabolism & Toxicology 2020;16:45-57. [DOI: 10.1080/17425255.2020.1702022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
39 Low JTS, Rohde G, Pittordou K, Candy B, Davis S, Marshall A, Stone P. Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals. J Hepatol 2018;69:1260-73. [PMID: 30243996 DOI: 10.1016/j.jhep.2018.08.028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
40 Schenker S, Bissell DM, Blei AT. Hepatology over the years. Hepatology 2006;43:S6-S12. [PMID: 16447280 DOI: 10.1002/hep.21061] [Reference Citation Analysis]
41 Wu J, Mao W, Li X. Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis. Gastroenterol Res Pract 2020;2020:4107219. [PMID: 32714387 DOI: 10.1155/2020/4107219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Yang W, Chen E, Bi H, Bai L, Chen X, Feng P, Tang H. Different models in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Annals of Hepatology 2012;11:311-9. [DOI: 10.1016/s1665-2681(19)30925-1] [Cited by in Crossref: 10] [Article Influence: 1.0] [Reference Citation Analysis]
43 Meriggi F, Graffeo M. Clinical Characterisation and Management of the Main Treatment-Induced Toxicities in Patients with Hepatocellular Carcinoma and Cirrhosis. Cancers (Basel) 2021;13:584. [PMID: 33540870 DOI: 10.3390/cancers13030584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Lee SK, Song MJ, Kim SH, Park M. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study. PLoS One 2019;14:e0216173. [PMID: 31048923 DOI: 10.1371/journal.pone.0216173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
45 Murata M, Kato TS, Kuwaki K, Yamamoto T, Dohi S, Amano A. Preoperative hepatic dysfunction could predict postoperative mortality and morbidity in patients undergoing cardiac surgery: Utilization of the MELD scoring system. International Journal of Cardiology 2016;203:682-9. [DOI: 10.1016/j.ijcard.2015.10.181] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
46 Lebrec D, Thabut D, Oberti F, Perarnau JM, Condat B, Barraud H, Saliba F, Carbonell N, Renard P, Ramond MJ. Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology. 2010;138:1755-1762. [PMID: 20102716 DOI: 10.1053/j.gastro.2010.01.040] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 7.7] [Reference Citation Analysis]
47 Lv XH, Chen YS, Liu HB, Wang BY, Sun MJ, Song M. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis. Shijie Huaren Xiaohua Zazhi 2010; 18(29): 3084-3088 [DOI: 10.11569/wcjd.v18.i29.3084] [Reference Citation Analysis]
48 Carrion AF, Radhakrishnan R, Martin P. Diagnosis and management of renal dysfunction in patients with cirrhosis. Expert Review of Gastroenterology & Hepatology 2020;14:1-7. [DOI: 10.1080/17474124.2020.1708190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
49 Jin JY, Zheng YB, Zheng J, Liu J, Mao YJ, Chen SG, Gao ZL, Zheng RQ. 2D shear wave elastography combined with MELD improved prognostic accuracy in patients with acute-on-chronic hepatitis B liver failure. Eur Radiol 2018;28:4465-74. [PMID: 29696433 DOI: 10.1007/s00330-018-5336-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
50 Yin Y, Cheng JW, Chen FY, Chen XX, Zhang X, Huang A, Guo DZ, Wang YP, Cao Y, Fan J, Zhou J, Yang XR. A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma. Ann Transl Med 2021;9:774. [PMID: 34268387 DOI: 10.21037/atm-20-7842] [Reference Citation Analysis]
51 Grancini V, Trombetta M, Lunati ME, Boselli ML, Gatti S, Donato MF, Palmieri E, Resi V, Pugliese G, Bonadonna RC, Orsi E. Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients. J Hepatol 2019;70:954-62. [PMID: 30677460 DOI: 10.1016/j.jhep.2019.01.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
52 Matsuo M, Murata S, Hasegawa S, Hatada Y, Ohtsuka M, Taniguchi H. Novel liver fibrosis model in Macaca fascicularis induced by thioacetamide. Sci Rep 2020;10:2450. [PMID: 32051422 DOI: 10.1038/s41598-020-58739-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Dabbous H, Sakr M, Abdelhakam S, Montasser I, Bahaa M, Said H, El-Meteini M. Living donor liver transplantation for high model for end-stage liver disease score: What have we learned? World J Hepatol 2016; 8(22): 942-948 [PMID: 27574548 DOI: 10.4254/wjh.v8.i22.942] [Reference Citation Analysis]
54 Ojima T, Nakamori M, Nakamura M, Katsuda M, Hayata K, Kato T, Kitadani J, Tabata H, Takeuchi A, Yamaue H. Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer. British Journal of Surgery 2017;104:1003-9. [DOI: 10.1002/bjs.10548] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
55 Ecochard M, Boillot O, Guillaud O, Roman S, Adham M, Mion F, Dumortier J. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients. Clin Transplant 2011;25:755-65. [PMID: 21158918 DOI: 10.1111/j.1399-0012.2010.01366.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
56 Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, O'Beirne J, Fox R, Skowronska A, Palmer D, Yeo W, Mo F, Lai P, Iñarrairaegui M, Chan SL, Sangro B, Miksad R, Tada T, Kumada T, Toyoda H. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 2015;33:550-8. [PMID: 25512453 DOI: 10.1200/JCO.2014.57.9151] [Cited by in Crossref: 802] [Cited by in F6Publishing: 406] [Article Influence: 100.3] [Reference Citation Analysis]
57 Wan SZ, Nie Y, Zhang Y, Liu C, Zhu X. Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department. Dis Markers 2020;2020:5193028. [PMID: 32148566 DOI: 10.1155/2020/5193028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
58 王宪波, 高方媛. 慢加急性肝衰竭: 东西方诊断和预后的差异. 世界华人消化杂志 2017; 25(21): 1910-1920 [DOI: 10.11569/wcjd.v25.i21.1910] [Reference Citation Analysis]
59 Nuthalapati A, Schluterman N, Khanna A, Greenberg D, Thuluvath PJ. Impact of Acute Kidney Injury on Mortality of Patients Hospitalized for Complications of Cirrhosis. J Clin Exp Hepatol 2017;7:290-9. [PMID: 29234192 DOI: 10.1016/j.jceh.2017.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
60 Kim J, Randhawa H, Sands D, Lambe S, Puglia M, Serrano PE, Pinthus JH. Muscle-Invasive Bladder Cancer in Patients with Liver Cirrhosis: A Review of Pertinent Considerations. BLC 2021;7:261-78. [DOI: 10.3233/blc-211536] [Reference Citation Analysis]
61 Dumortier J, Besch C, Moga L, Coilly A, Conti F, Corpechot C, Bello AD, Faitot F, Francoz C, Hilleret MN, Houssel-Debry P, Jezequel C, Lavayssière L, Neau-Cransac M, Erard-Poinsot D, de Lédinghen V, Bourlière M, Bureau C, Ganne-Carrié N. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP IN LIVER TRANSPLANTATION. Clin Res Hepatol Gastroenterol 2021;:101774. [PMID: 34332131 DOI: 10.1016/j.clinre.2021.101774] [Reference Citation Analysis]
62 Kusuyama Y, Matsumoto K, Okada S, Wakabayashi K, Takeuchi N, Yura Y. Rapidly progressing osteomyelitis of the mandible. Case Rep Dent 2013;2013:249615. [PMID: 24349802 DOI: 10.1155/2013/249615] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
63 Grancini V, Trombetta M, Lunati ME, Zimbalatti D, Boselli ML, Gatti S, Donato MF, Resi V, D’ambrosio R, Aghemo A, Pugliese G, Bonadonna RC, Orsi E. Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease. Journal of Hepatology 2015;63:1484-90. [DOI: 10.1016/j.jhep.2015.08.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
64 Taguchi K, Miyasato M, Watanabe H, Sakai H, Tsuchida E, Horinouchi H, Kobayashi K, Maruyama T, Otagiri M. Alteration in the Pharmacokinetics of Hemoglobin-Vesicles in a Rat Model of Chronic Liver Cirrhosis Is Associated with Kupffer Cell Phagocyte Activity. Journal of Pharmaceutical Sciences 2011;100:775-83. [DOI: 10.1002/jps.22286] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
65 Mai RY, Wang YY, Bai T, Chen J, Xiang BD, Wu GB, Wu FX, Li LQ, Ye JZ. Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients. Cancer Manag Res. 2019;11:8799-8806. [PMID: 31632139 DOI: 10.2147/cmar.s213432] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
66 Chen RC, Cai YJ, Wu JM, Wang XD, Song M, Wang YQ, Zheng MH, Chen YP, Lin Z, Shi KQ. Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis. J Viral Hepat 2017;24:238-45. [PMID: 27862671 DOI: 10.1111/jvh.12638] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
67 Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol 2009;9:72. [PMID: 19778459 DOI: 10.1186/1471-230X-9-72] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
68 Angeli P, Rodríguez E, Piano S, Ariza X, Morando F, Solà E, Romano A, García E, Pavesi M, Risso A, Gerbes A, Willars C, Bernardi M, Arroyo V, Ginès P; CANONIC Study Investigators of EASL-CLIF Consortium. Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis. Gut 2015;64:1616-22. [PMID: 25311034 DOI: 10.1136/gutjnl-2014-307526] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
69 Jiang H, Jin Y, Yan H, Xu Z, Yang B, He Q, Luo P. Hepatotoxicity of FDA-approved small molecule kinase inhibitors. Expert Opin Drug Saf 2021;20:335-48. [PMID: 33356646 DOI: 10.1080/14740338.2021.1867104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Jensen C, Holm Nielsen S, Eslam M, Genovese F, Nielsen MJ, Vongsuvanh R, Uchila R, van der Poorten D, George J, Karsdal MA, Leeming DJ, Willumsen N. Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma - A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients. J Hepatocell Carcinoma 2020;7:301-13. [PMID: 33204663 DOI: 10.2147/JHC.S275008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
71 Luo R, Greenberg A, Stone CD. Increasing Volume but Decreasing Mortality of Hospitalized Hepatitis C Patients in the United States, 2005 to 2011. J Clin Gastroenterol 2015;49:620-7. [PMID: 25203363 DOI: 10.1097/MCG.0000000000000216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Puentes JCP, Rocha H, Nicolau S, Ferrão G. Effectiveness of the MELD/Na Score and the Child-Pugh Score for the Identification of Palliative Care Needs in Patients with Cirrhosis of the Liver. Indian J Palliat Care 2018;24:526-8. [PMID: 30410269 DOI: 10.4103/IJPC.IJPC_97_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
73 Wittmer VL, Lima RT, Maia MC, Duarte H, Paro FM. RESPIRATORY AND SYMPTOMATIC IMPACT OF ASCITES RELIEF BY PARACENTESIS IN PATIENTS WITH HEPATIC CIRRHOSIS. Arq Gastroenterol 2020;57:64-8. [PMID: 32294737 DOI: 10.1590/S0004-2803.202000000-11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
74 Soltys KA, Soto-Gutiérrez A, Nagaya M, Baskin KM, Deutsch M, Ito R, Shneider BL, Squires R, Vockley J, Guha C. Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol. 2010;53:769-774. [PMID: 20667616 DOI: 10.1016/j.jhep.2010.05.010] [Cited by in Crossref: 111] [Cited by in F6Publishing: 91] [Article Influence: 9.3] [Reference Citation Analysis]
75 Kao HK, Guo LF, Cheng MH, Chen IH, Liao CT, Fang KH, Yu JS, Chang KP. Predicting postoperative morbidity and mortality by model for endstage liver disease score for patients with head and neck cancer and liver cirrhosis. Head Neck 2011;33:529-34. [PMID: 20665744 DOI: 10.1002/hed.21486] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
76 Edelson JC, Rockey DC. Letter to the Editor: Complications Associated With Anesthesia Services in Endoscopic Procedures Among Patients With Cirrhosis. Hepatology 2021. [PMID: 34125447 DOI: 10.1002/hep.31892] [Reference Citation Analysis]
77 Zhou Z, Long L, Huang L, Yang T, Huang Z. Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min. Radiol med 2017;122:239-47. [DOI: 10.1007/s11547-016-0719-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
78 Wang D, Chen TW, Zhang XM, Li J, Zeng NL, Li L, Tang YL, Huang YC, Li R, Chen F, Chen YL. Liver Lobe Based Multi-Echo Gradient Recalled Echo T2*-Weighted Imaging in Chronic Hepatitis B-Related Cirrhosis: Association with the Presence and Child-Pugh Class of Cirrhosis. PLoS One 2016;11:e0154545. [PMID: 27171422 DOI: 10.1371/journal.pone.0154545] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
79 Yu DS, Chang H, Sommer CM, Qu WL, Xu WJ, Yang RJ, Zhao P. Efficacy and safety of percutaneous microwave coagulation therapy followed by 125I seed brachytherapy for VX2 hepatic tumors in a rabbit model. Exp Ther Med 2013;6:159-63. [PMID: 23935738 DOI: 10.3892/etm.2013.1088] [Reference Citation Analysis]
80 Zhou L, Dong PL, Ding HG. Comparison scoring model of severe viral hepatitis and model of end stage liver disease for the prognosis of patients with liver failure in China. World J Gastroenterol 2007; 13(21): 2999-3002 [PMID: 17589954 DOI: 10.3748/wjg.v13.i21.2999] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
81 Nagata H, Nishitai R, Shirota C, Zhang JL, Koch CA, Cai J, Awwad M, Schuurman HJ, Christians U, Abe M, Baranowska-Kortylewicz J, Platt JL, Fox IJ. Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology 2007;132:321-9. [PMID: 17241882 DOI: 10.1053/j.gastro.2006.10.013] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.0] [Reference Citation Analysis]
82 Hamed AE, Elsahar M, Elwan NM, El-Nakeep S, Naguib M, Soliman HH, Ahmed Aboubakr A, AbdelMaqsod A, Sedrak H, Assaad SN, Elwakil R, Esmat G, Salh S, Mostafa T, Mogawer S, Sadek SE, Saber MM, Ezelarab H, Mahmoud AA, Sultan S, El Kassas M, Kamal E, ElSayed NM, Moussa S. Managing diabetes and liver disease association. Arab J Gastroenterol 2018;19:166-79. [PMID: 30420265 DOI: 10.1016/j.ajg.2018.08.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
83 Lei JH, Peng F, Chen Z, Xiao XQ. Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis? BMC Infect Dis 2019;19:363. [PMID: 31039732 DOI: 10.1186/s12879-019-3988-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Radisavljevic MM, Bjelakovic GB, Nagorni AV, Stojanovic MP, Radojkovicn MD, Jovic JZ, Ignjatovic AM, Radisavljevic MM, Simonovic MM. Predictors of Mortality in Long-Term Follow-Up of Patients with Terminal Alcoholic Cirrhosis: Is It Time to Accept Remodeled Scores? Med Princ Pract. 2017;26:169-175. [PMID: 27676412 DOI: 10.1159/000451057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
85 Amann LF, Alraish R, Broeker A, Kaffarnik M, Wicha SG. Tigecycline Dosing Strategies in Critically Ill Liver-Impaired Patients. Antibiotics 2022;11:479. [DOI: 10.3390/antibiotics11040479] [Reference Citation Analysis]
86 Zhou P, Chen B, Miao X, Zhou J, Xiong L, Wen Y, Zou H. Comparison of FIB-4 Index and Child-Pugh Score in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. J Gastrointest Surg 2020;24:823-31. [DOI: 10.1007/s11605-019-04123-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
87 van Roekel C, Reinders MT, van der Velden S, Lam MG, Braat MN. Hepatobiliary Imaging in Liver-directed Treatments. Seminars in Nuclear Medicine 2019;49:227-36. [DOI: 10.1053/j.semnuclmed.2019.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Zhou Z, Long L, Qiu W, Cheng G, Huang L, Yang T, Huang Z. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic. Abdom Radiol 2017;42:2272-8. [DOI: 10.1007/s00261-017-1143-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
89 Peng Y, Qi X, Dai J, Li H, Guo X. Child-Pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis. Int J Clin Exp Med 2015;8:751-7. [PMID: 25785053] [Reference Citation Analysis]
90 Chan AW, Kumada T, Toyoda H, Tada T, Chong CC, Mo FK, Yeo W, Johnson PJ, Lai PB, Chan AT, To KF, Chan SL. Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma. J Gastroenterol Hepatol. 2016;31:1300-1306. [PMID: 26751608 DOI: 10.1111/jgh.13291] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 12.4] [Reference Citation Analysis]
91 Lee M, Tae H, Jun D, Ryu S, Choi Y, Kwak M, Kang J. 201Tl Heart-Liver Radioactivity Uptake Ratio and Prediction of Decompensation in Patients With Cirrhosis. Clinical Nuclear Medicine 2013;38:169-74. [DOI: 10.1097/rlu.0b013e31827087e3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
92 Marroni CA, Miranda D, Boemeke L, Fernandes SA. Phase Angle Bioelectrical Impedance Analysis (BIA) as a Biomarker Tool for Liver Disease. In: Patel VB, Preedy VR, editors. Biomarkers in Liver Disease. Dordrecht: Springer Netherlands; 2017. pp. 735-51. [DOI: 10.1007/978-94-007-7675-3_43] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
93 Delicque J, Hermida M, Piron L, Allimant C, Belgour A, Pageaux GP, Ben Bouallegue F, Assenat E, Mariano-Goulart D, Guiu B, Cassinotto C. Intra arterial treatment of hepatocellular carcinoma: Comparison of MELD score variations between radio-embolization and chemo-embolization. Diagn Interv Imaging 2019;100:689-97. [PMID: 31281074 DOI: 10.1016/j.diii.2019.05.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
94 Azar A, Devcic Z, Paz-Fumagalli R, Vidal LLC, McKinney JM, Frey G, Lewis AR, Ritchie C, Starr JS, Mody K, Toskich B. Albumin-bilirubin grade as a prognostic indicator for patients with non-hepatocellular primary and metastatic liver malignancy undergoing Yttrium-90 radioembolization using resin microspheres. J Gastrointest Oncol 2020;11:715-23. [PMID: 32953155 DOI: 10.21037/jgo.2020.04.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Caly WR, Abreu RM, Bitelman B, Carrilho FJ, Ono SK. Clinical Features of Refractory Ascites in Outpatients. Clinics (Sao Paulo). 2017;72:405-410. [PMID: 28792999 DOI: 10.6061/clinics/2017(07)03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
96 Li J, Huang L, Yan J, Zhou F, Liu C, Yan Y. Sorafenib in hepatocellular carcinoma: efficacy and predictive factors. Journal of Medical Colleges of PLA 2011;26:324-34. [DOI: 10.1016/s1000-1948(12)60028-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
97 Al Sibae MR, Cappell MS. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. Dig Dis Sci. 2011;56:977-987. [PMID: 20844956 DOI: 10.1007/s10620-010-1390-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
98 Scott RA, Austin AS, Kolhe NV, McIntyre CW, Selby NM. Acute kidney injury is independently associated with death in patients with cirrhosis. Frontline Gastroenterol 2013;4:191-7. [PMID: 24660054 DOI: 10.1136/flgastro-2012-100291] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
99 Mai RY, Zeng J, Mo YS, Liang R, Lin Y, Wu SS, Piao XM, Gao X, Wu GB, Li LQ, Ye JZ. Artificial Neural Network Model for Liver Cirrhosis Diagnosis in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma. Ther Clin Risk Manag 2020;16:639-49. [PMID: 32764948 DOI: 10.2147/TCRM.S257218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Orsi E, Grancini V, Menini S, Aghemo A, Pugliese G. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes? Liver Int. 2017;37:950-962. [PMID: 27943508 DOI: 10.1111/liv.13337] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
101 Wang Y, Zhong J, Su Z, Huang J, Lu S, Xiang B, Ma L, Qi L, Ou B, Li L. Albumin–bilirubin versus Child–Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. British Journal of Surgery 2016;103:725-34. [DOI: 10.1002/bjs.10095] [Cited by in Crossref: 128] [Cited by in F6Publishing: 138] [Article Influence: 21.3] [Reference Citation Analysis]
102 Hagag NA, Ali YBM, Elsharawy AA, Talaat RM. Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression. J Gastrointest Cancer. 2020;51:234-241. [PMID: 31028536 DOI: 10.1007/s12029-019-00234-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
103 Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol. 2010;52:605-613. [PMID: 20185192 DOI: 10.1016/j.jhep.2009.11.025] [Cited by in Crossref: 155] [Cited by in F6Publishing: 125] [Article Influence: 12.9] [Reference Citation Analysis]
104 Wu SL, Zheng YX, Tian ZW, Chen MS, Tan HZ. Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy. World J Clin Cases 2018; 6(15): 995-1006 [PMID: 30568954 DOI: 10.12998/wjcc.v6.i15.995] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
105 Mukherjee RM, Shravanti GV, Jakkampudi A, Kota R, Jangala AL, Reddy PB, Rao PN, Gupta R, Reddy DN. Reduced Expression of DNA Damage Repair Genes High Mobility Group Box1 and Poly(ADP-ribose) Polymerase1 in Inactive Carriers of Hepatitis B Virus Infection-A Possible Stage of Viral Integration. J Clin Exp Hepatol 2013;3:89-95. [PMID: 25755481 DOI: 10.1016/j.jceh.2013.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
106 Watany MM, Hagag RY, Okda HI. Circulating miR-21, miR-210 and miR-146a as potential biomarkers to differentiate acute tubular necrosis from hepatorenal syndrome in patients with liver cirrhosis: a pilot study. Clin Chem Lab Med 2018;56:739-47. [PMID: 29303765 DOI: 10.1515/cclm-2017-0483] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
107 Attia D, Rodt T, Marquardt S, Hinrichs J, Meyer BC, Gebel M, Wacker F, Manns MP, Potthoff A. Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient. Abdom Radiol 2019;44:1127-34. [DOI: 10.1007/s00261-018-1795-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
108 Yagmur E, Trautwein C, Gressner AM, Tacke F. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am J Gastroenterol. 2006;101:1244-1252. [PMID: 16771945 DOI: 10.1111/j.1572-0241.2006.00543.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
109 Haj M, Rockey DC. Predictors of clinical outcomes in cirrhosis patients. Curr Opin Gastroenterol. 2018;34:266-271. [PMID: 29846263 DOI: 10.1097/mog.0000000000000450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
110 Tu CY, Chen CH. Spontaneous bacterial empyema. Curr Opin Pulm Med. 2012;18:355-358. [PMID: 22450302 DOI: 10.1097/mcp.0b013e328352b50f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
111 Stauber RE, Wagner D, Stadlbauer V, Palma S, Gurakuqi G, Kniepeiss D, Iberer F, Smolle KH, Haas J, Trauner M. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis. Liver Int. 2009;29:1516-1520. [PMID: 19732329 DOI: 10.1111/j.1478-3231.2009.02104.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
112 Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824-828, discussion 824-828. [PMID: 16327492 DOI: 10.1097/01.sla.0000189131.90876.9e.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Vitalis Z, Altorjay I, Tornai I, Palatka K, Kacska S, Palyu E, Tornai D, Udvardy M, Harsfalvi J, Dinya T. Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis. Hum Immunol. 2011;72:348-354. [PMID: 21262313 DOI: 10.1016/j.humimm.2011.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
114 Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl. 2007;13:1174-1180. [PMID: 17663415 DOI: 10.1002/lt.21197] [Cited by in Crossref: 162] [Cited by in F6Publishing: 142] [Article Influence: 10.8] [Reference Citation Analysis]
115 Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut. 2007;56:1283-1290. [PMID: 17452425 DOI: 10.1136/gut.2006.102764] [Cited by in Crossref: 136] [Cited by in F6Publishing: 117] [Article Influence: 9.1] [Reference Citation Analysis]
116 Moan AS. The evaluation of liver dysfunction: when to suspect portal hypertension. JAAPA 2009;22:38-42. [PMID: 19452820 DOI: 10.1097/01720610-200904000-00010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
117 Daniele G, Costa N, Lorusso V, Costa-Maia J, Pache I, Pirisi M. Methodological assessment of HCC literature. Ann Oncol 2013;24 Suppl 2:ii6-14. [PMID: 23715943 DOI: 10.1093/annonc/mdt052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
118 Parsons HM, Chu Q, Karlitz JJ, Stevens JL, Harlan LC. Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States. Liver Cancer 2017;6:216-26. [PMID: 29234628 DOI: 10.1159/000473862] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
119 Chen R, Wang X, Dong J, Lin Z, Wu J, Cai Y, Shi K. A MELD-based nomogram for predicting 3-month mortality of patients with acute-on-chronic hepatitis B liver failure. Clinica Chimica Acta 2017;468:195-200. [DOI: 10.1016/j.cca.2017.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
120 Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M, Iida T, Hayata K, Yamaue H. Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg. 2009;13:1821-1830. [PMID: 19655208 DOI: 10.1007/s11605-009-0973-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 4.6] [Reference Citation Analysis]
121 Huang L, Li J, Yan JJ, Liu CF, Wu MC, Yan YQ. Prealbumin is predictive for postoperative liver insufficiency in patients undergoing liver resection. World J Gastroenterol 2012; 18(47): 7021-7025 [PMID: 23323003 DOI: 10.3748/wjg.v18.i47.7021] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
122 Pinato DJ, Kaneko T, Saeed A, Pressiani T, Kaseb A, Wang Y, Szafron D, Jun T, Dharmapuri S, Naqash AR, Muzaffar M, Navaid M, Lee CJ, Bulumulle A, Yu B, Paul S, Nimkar N, Bettinger D, Hildebrand H, Abugabal YI, Ang C, Marron TU, Khan U, Personeni N, Rimassa L, Huang YH. Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade. Cancers (Basel) 2020;12:E1862. [PMID: 32664319 DOI: 10.3390/cancers12071862] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
123 Tacke F, Trautwein C, Yagmur E, Hellerbrand C, Wiest R, Brenner DA, Schnabl B. Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course. J Gastroenterol Hepatol 2007;22:1256-64. [DOI: 10.1111/j.1440-1746.2006.04621.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
124 Takeda Y, Fujita Y, Bessho R, Sato M, Abe T, Yanagimachi T, Sakagami H, Abiko A, Takiyama Y, Ota T, Haneda M. Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test. BMC Endocr Disord 2019;19:99. [PMID: 31615494 DOI: 10.1186/s12902-019-0428-6] [Reference Citation Analysis]
125 Prieto M, Aguilera V, Berenguer M, Pina R, Benlloch S. Selección de candidatos para trasplante hepático. Gastroenterología y Hepatología 2007;30:42-53. [DOI: 10.1157/13097451] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
126 Tsai YC, Sou FM, Liu YW, Wu YJ, Yong CC, Chen DW, Huang PY, Cho WR, Chuang CH, Hsiao CC, Hu TH, Tsai MC. Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection. BMC Gastroenterol 2021;21:386. [PMID: 34666694 DOI: 10.1186/s12876-021-01944-w] [Reference Citation Analysis]
127 Durand F, Buyse S, Francoz C, Laouénan C, Bruno O, Belghiti J, Moreau R, Vilgrain V, Valla D. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol. 2014;60:1151-1157. [PMID: 24607622 DOI: 10.1016/j.jhep.2014.02.026] [Cited by in Crossref: 209] [Cited by in F6Publishing: 180] [Article Influence: 26.1] [Reference Citation Analysis]
128 Okazaki E, Yamamoto A, Nishida N, Hamuro M, Ogino R, Hosono M, Shimatani Y, Tsutsumi S, Hamamoto S, Sohgawa E, Jogo A, Miki Y. Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification. Br J Radiol 2016;89:20150945. [PMID: 27164029 DOI: 10.1259/bjr.20150945] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
129 Chen Q, Li F, Zhong C, Zou Y, Li Z, Gao Y, Zou Q, Xia Y, Wang K, Shen F. Inflammation Score System using Preoperative Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma after Hepatectomy: A Cohort Study. J Cancer 2020;11:4947-56. [PMID: 32742442 DOI: 10.7150/jca.45274] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
130 Dziodzio T, Öllinger R, Schöning W, Rothkäppel A, Nikolov R, Juraszek A, Ritschl PV, Stockmann M, Pratschke J, Jara M. Validation of a new prognostic model to predict short and medium-term survival in patients with liver cirrhosis. BMC Gastroenterol 2020;20:265. [PMID: 32787947 DOI: 10.1186/s12876-020-01407-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Turner BJ, Liang Y, Singal AG. FIB-4 and imaging for measuring fibrosis in hepatitis C virus. Eur J Gastroenterol Hepatol 2017;29:192-8. [PMID: 27755232 DOI: 10.1097/MEG.0000000000000766] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
132 Santos MS, Abreu PH, García-Laencina PJ, Simão A, Carvalho A. A new cluster-based oversampling method for improving survival prediction of hepatocellular carcinoma patients. J Biomed Inform 2015;58:49-59. [PMID: 26423562 DOI: 10.1016/j.jbi.2015.09.012] [Cited by in Crossref: 67] [Cited by in F6Publishing: 21] [Article Influence: 9.6] [Reference Citation Analysis]
133 Granito A, Bolondi L. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis. The Lancet Oncology 2017;18:e101-12. [DOI: 10.1016/s1470-2045(16)30569-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 35] [Article Influence: 12.4] [Reference Citation Analysis]
134 Wang ZX, Peng W, Zhang XY, Wen TF, Li C. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy. Medicine (Baltimore) 2021;100:e24476. [PMID: 33725934 DOI: 10.1097/MD.0000000000024476] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Sezer S, Karakan S, Erişmiş B, Çolak T, Haberal M. Risk factors for kidney impairment and differential impact of liver transplantation on renal function. Transplant Proc 2011;43:609-11. [PMID: 21440776 DOI: 10.1016/j.transproceed.2011.01.045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
136 Wang D, Zhan X, Wu R, You Y, Chen W, Duan L. Assessment of Pyroptosis-Related Indicators as Potential Biomarkers and Their Association with Severity in Patients with Liver Cirrhosis. J Inflamm Res 2021;14:3185-96. [PMID: 34285542 DOI: 10.2147/JIR.S319213] [Reference Citation Analysis]
137 Wu P, Guo L, Yu S, Zeng N, Liu Y, Yu J, Zhang Z, Lu K, Sun L, Wang C, Chang Y, Lu Y, Shen Y, Tai S, Chuang Y, Ho JA, Huang K, Wu Y, Liu T. Noninvasive assessment of liver function reserve with fluorescent dosimetry of indocyanine green. Biomed Opt Express 2022;13:1995. [DOI: 10.1364/boe.446749] [Reference Citation Analysis]
138 Cholongitas E, Marelli L, Kerry A, Senzolo M, Goodier DW, Nair D, Thomas M, Patch D, Burroughs AK. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007;13:523-9. [DOI: 10.1002/lt.20994] [Cited by in Crossref: 109] [Cited by in F6Publishing: 91] [Article Influence: 7.3] [Reference Citation Analysis]
139 Altorjay I, Vitalis Z, Tornai I, Palatka K, Kacska S, Farkas G, Udvardy M, Harsfalvi J, Dinya T, Orosz P. Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis. J Hepatol. 2010;53:484-491. [PMID: 20605050 DOI: 10.1016/j.jhep.2010.03.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
140 Xi RR, Han T, Lv JY, Cai JJ. Comparison of five different scoring models for predicting short-term mortality in patients with alcohol-related acute-on-chronic liver failure. Shijie Huaren Xiaohua Zazhi 2018; 26(6): 365-372 [DOI: 10.11569/wcjd.v26.i6.365] [Reference Citation Analysis]
141 Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl. 2006;12:65-71. [PMID: 16382473 DOI: 10.1002/lt.20560] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
142 Ricardo Flores-rendón Á, Alberto González-gonzález J, García-compean D, Jesús Maldonado-garza H, Azael Garza-galindo A. Model for end stage of liver disease (MELD) is better than the Child-Pugh score for predicting in-hospital mortality related to esophageal variceal bleeding. Annals of Hepatology 2008;7:230-4. [DOI: 10.1016/s1665-2681(19)31853-8] [Cited by in Crossref: 18] [Article Influence: 1.3] [Reference Citation Analysis]
143 Thüring J, Rippel O, Haarburger C, Merhof D, Schad P, Bruners P, Kuhl CK, Truhn D. Multiphase CT-based prediction of Child-Pugh classification: a machine learning approach. Eur Radiol Exp 2020;4:20. [PMID: 32249336 DOI: 10.1186/s41747-020-00148-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Omar Jáquez Quintana J, García-compean D, Alberto González González J, Zacarías Villarreal Pérez J, Javier Lavalle González F, Elsa Muñoz Espinosa L, López Hernández P, Reyes Cabello E, Redondo Villarreal E, Flores Rendón R, Maldonado Garza H. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. Annals of Hepatology 2011;10:56-62. [DOI: 10.1016/s1665-2681(19)31588-1] [Cited by in Crossref: 36] [Article Influence: 3.3] [Reference Citation Analysis]
145 Cagin YF, Bilgic Y, Berber İ, Yildirim O, Erdogan MA, Firat F, Arslan AK, Colak C, Seckin Y, Harputluoglu M. The risk factors of portal vein thrombosis in patients with liver cirrhosis. Exp Ther Med 2019;17:3189-94. [PMID: 30936992 DOI: 10.3892/etm.2019.7300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
146 Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. Dig Liver Dis. 2008;40:882-889. [PMID: 18339595 DOI: 10.1016/j.dld.2008.01.015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
147 Fang T, Long G, Wang D, Liu X, Xiao L, Mi X, Su W, Zhou L, Zhou L. A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure After Hepatectomy in HCC Patients. Front Oncol 2021;11:667496. [PMID: 34277414 DOI: 10.3389/fonc.2021.667496] [Reference Citation Analysis]
148 Lee JC, Kim JS, Kim HW, Cho IK, Lee J, Jang ES, Lee SH, Hwang JH, Kim JW, Jeong SH, Kim J. Outcome of endoscopic retrograde cholangiopancreatography in patients with clinically defined decompensated liver cirrhosis. J Dig Dis 2018;19:605-13. [PMID: 30126061 DOI: 10.1111/1751-2980.12661] [Reference Citation Analysis]
149 Sha J, Dong Y, Niu H. A prospective study of risk factors for in-hospital mortality in patients with malignant obstructive jaundice undergoing percutaneous biliary drainage. Medicine (Baltimore) 2019;98:e15131. [PMID: 30985679 DOI: 10.1097/MD.0000000000015131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, Nevens F, Fernández J, To U, García-Tsao G, Schnabl B. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers 2016;2:16041. [PMID: 27277335 DOI: 10.1038/nrdp.2016.41] [Cited by in Crossref: 159] [Cited by in F6Publishing: 144] [Article Influence: 26.5] [Reference Citation Analysis]
151 Mai R, Zeng J, Lu H, Liang R, Lin Y, Piao X, Gao X, Wu G, Wu F, Ma L, Xiang B, Li L, Ye J. Combining Aspartate Aminotransferase-to-Platelet Ratio Index with Future Liver Remnant to Assess Preoperative Hepatic Functional Reserve in Patients with Hepatocellular Carcinoma. J Gastrointest Surg 2021;25:688-97. [DOI: 10.1007/s11605-020-04575-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
152 Yuan WH, Li AF, Hsu HC, Hu YS, Lee RC. Initial clinical radiological findings and staging to predict prognosis of primary hepatic angiosarcoma: A retrospective analysis. PLoS One 2019;14:e0225043. [PMID: 31710641 DOI: 10.1371/journal.pone.0225043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
153 Chen XL, Chen TW, Zhang XM, Li ZL, Zeng NL, Li T, Wang D, Li J, Fang ZJ, Li H. Quantitative assessment of the presence and severity of cirrhosis in patients with hepatitis B using right liver lobe volume and spleen size measured at magnetic resonance imaging. PLoS One. 2014;9:e89973. [PMID: 24594920 DOI: 10.1371/journal.pone.0089973] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
154 Xu Y, Li N, Lu M, Dixon E, Myers RP, Jolley RJ, Quan H. Comparison of risk adjustment methods in patients with liver disease using electronic medical record data. BMC Gastroenterol 2017;17:5. [PMID: 28061757 DOI: 10.1186/s12876-016-0559-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
155 Heimbach T, Chen Y, Chen J, Dixit V, Parrott N, Peters SA, Poggesi I, Sharma P, Snoeys J, Shebley M, Tai G, Tse S, Upreti VV, Wang YH, Tsai A, Xia B, Zheng M, Zhu AZX, Hall S. Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective. Clin Pharmacol Ther 2021;110:297-310. [PMID: 33270249 DOI: 10.1002/cpt.2125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
156 Jiang Y, Chen Y, Chen L, Yao W, Guan J, Liu X, Wei X, Lin X. Impaired circulating CD56dim NK cells are associated with decompensation of HBV-related cirrhosis. Hum Immunol 2020;81:32-40. [PMID: 31735440 DOI: 10.1016/j.humimm.2019.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
157 Novelli G, Rossi M, Ferretti G, Pugliese F, Travaglia D, Guidi S, Novelli S, Lai Q, Morabito V, Berloco PB. Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure. Transplant Proc 2010;42:1182-7. [PMID: 20534256 DOI: 10.1016/j.transproceed.2010.03.095] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
158 Lee S, Choi D, Jeong WK. Hepatic enhancement of Gd-EOB-DTPA-enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis. J Magn Reson Imaging. 2016;44:1339-1345. [PMID: 27197633 DOI: 10.1002/jmri.25288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
159 Nie Y, Liu LX, Chen T, Zhang Y, Zhu X. Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study. Epidemiol Infect 2021;149:e26. [PMID: 33397544 DOI: 10.1017/S0950268820003143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
160 Cai X, Liang X, Yu T, Liang Y, Jing R, Jiang W, Li J, Ying H. Liver cirrhosis grading Child-Pugh class B: a Goliath to challenge in laparoscopic liver resection? Hepatobiliary Surg Nutr. 2015;4:391-397. [PMID: 26734623 DOI: 10.3978/j.issn.2304-3881.2015.09.02] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
161 Kaseb AO, Xiao L, Hassan MM, Chae YK, Lee JS, Vauthey JN, Krishnan S, Cheung S, Hassabo HM, Aloia T. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. J Natl Cancer Inst. 2014;106. [PMID: 24815863 DOI: 10.1093/jnci/dju088] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
162 Pereira RCR, Heming CAM, Tejo TR, de Oliveira TCL, da Silva RDSU, Parente DB. Use of the LI-RADS classification in patients with cirrhosis due to infection with hepatitis B, C, or D, or infected with hepatitis B and D. Radiol Bras 2020;53:14-20. [PMID: 32313331 DOI: 10.1590/0100-3984.2018.0077] [Reference Citation Analysis]
163 Pérez-San-Gregorio MÁ, Martín-Rodríguez A, Domínguez-Cabello E, Fernández-Jiménez E, Bernardos-Rodríguez Á. Quality of life and mental health comparisons among liver transplant recipients and cirrhotic patients with different self-perceptions of health. J Clin Psychol Med Settings 2013;20:97-106. [PMID: 22622855 DOI: 10.1007/s10880-012-9309-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
164 Ye JZ, Mai RY, Guo WX, Wang YY, Ma L, Xiang BD, Cheng SQ, Li LQ. Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study. BMC Cancer 2020;20:1036. [PMID: 33115425 DOI: 10.1186/s12885-020-07480-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Kukla M, Skladany L, Menżyk T, Derra A, Stygar D, Skonieczna M, Hudy D, Nabrdalik K, Gumprecht J, Marlicz W, Koulaouzidis A, Koller T. Irisin in Liver Cirrhosis. J Clin Med 2020;9:E3158. [PMID: 33003490 DOI: 10.3390/jcm9103158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Zhou ZP, Long LL, Qiu WJ, Cheng G, Huang LJ, Yang TF, Huang ZK. Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla. BMC Med Imaging 2017;17:20. [PMID: 28249571 DOI: 10.1186/s12880-017-0192-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
167 Chen SH, Wan QS, Wang T, Zhang KH. Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis. Biomed Res Int 2020;2020:7170457. [PMID: 32280697 DOI: 10.1155/2020/7170457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Dyk P, Weiner A, Badiyan S, Myerson R, Parikh P, Olsen J. Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child-Pugh score classification system. Practical Radiation Oncology 2015;5:176-82. [DOI: 10.1016/j.prro.2014.09.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
169 Dar SH, Rahim M, Hosseini DK, Sarfraz K. Impact of liver cirrhosis on ST-elevation myocardial infarction related shock and interventional management, a nationwide analysis. World J Hepatol 2022; 14(4): 766-777 [DOI: 10.4254/wjh.v14.i4.766] [Reference Citation Analysis]
170 Fox RK. When to Consider Liver Transplant During the Management of Chronic Liver Disease. Medical Clinics of North America 2014;98:153-68. [DOI: 10.1016/j.mcna.2013.09.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
171 Xu Y, Sun C, Han B, Xi Y, Zhang M, Yang J, Chen Z. High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma. Oncol Lett 2020;20:509-16. [PMID: 32565976 DOI: 10.3892/ol.2020.11588] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
172 Weersink RA, Timmermans L, Monster-Simons MH, Mol PGM, Metselaar HJ, Borgsteede SD, Taxis K. Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment. Front Pharmacol 2019;10:1031. [PMID: 31607904 DOI: 10.3389/fphar.2019.01031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
173 Francoz C, Belghiti J, Durand F. Indications of liver transplantation in patients with complications of cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:175-190. [PMID: 17223504 DOI: 10.1016/j.bpg.2006.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
174 Francoz C, Nadim MK, Durand F. Kidney biomarkers in cirrhosis. J Hepatol. 2016;65:809-824. [PMID: 27238754 DOI: 10.1016/j.jhep.2016.05.025] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 11.8] [Reference Citation Analysis]
175 Marasco G, Sadalla S, Vara G, Golfieri R, Festi D, Colecchia A, Renzulli M. Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning. Can J Gastroenterol Hepatol. 2021;2021:6669480. [PMID: 33505942 DOI: 10.1155/2021/6669480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
176 Wlazlo N, van Greevenbroek MM, Curvers J, Schoon EJ, Friederich P, Twisk JW, Bravenboer B, Stehouwer CD. Diabetes mellitus at the time of diagnosis of cirrhosis is associated with higher incidence of spontaneous bacterial peritonitis, but not with increased mortality. Clin Sci (Lond). 2013;125:341-348. [PMID: 23566037 DOI: 10.1042/cs20120596] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
177 Pei Y, Zhang Z, Mba'nbo-Koumpa AA, Chen X, Zhang W. Improved survival following splenectomy combined with curative treatments for hepatocellular carcinoma in Child B patients: A propensity score matching study. Hepatol Res 2019;49:177-88. [PMID: 30347506 DOI: 10.1111/hepr.13276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
178 Michel M, Hess C, Kaps L, Kremer WM, Hilscher M, Galle PR, Moehler M, Schattenberg JM, Wörns MA, Labenz C, Nagel M. Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis. Sci Rep 2021;11:20506. [PMID: 34654829 DOI: 10.1038/s41598-021-00119-7] [Reference Citation Analysis]
179 Tripathi A, Tiwari B, Patil R, Khanna V, Singh V. The role of salivary caffeine clearance in the diagnosis of chronic liver disease. J Oral Biol Craniofac Res 2015;5:28-33. [PMID: 25853045 DOI: 10.1016/j.jobcr.2014.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
180 Vidot H, Cvejic E, Finegan LJ, Shores EA, Bowen DG, Strasser SI, McCaughan GW, Carey S, Allman-Farinelli M, Shackel NA. Supplementation with Synbiotics and/or Branched Chain Amino Acids in Hepatic Encephalopathy: A Pilot Randomised Placebo-Controlled Clinical Study. Nutrients 2019;11:E1810. [PMID: 31390762 DOI: 10.3390/nu11081810] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
181 Xavier SA, Vilas-boas R, Boal Carvalho P, Magalhães JT, Marinho CM, Cotter JB. Assessment of prognostic performance of Albumin–Bilirubin, Child–Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding: . European Journal of Gastroenterology & Hepatology 2018;30:652-8. [DOI: 10.1097/meg.0000000000001087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
182 Li M, Wang J, Song J, Shen F, Song L, Ni X, Suo T, Liu H, Zhong M, Liu H. Preoperative ICG Test to Predict Posthepatectomy Liver Failure and Postoperative Outcomes in Hilar Cholangiocarcinoma. Biomed Res Int 2021;2021:8298737. [PMID: 33681380 DOI: 10.1155/2021/8298737] [Reference Citation Analysis]
183 Cholongitas E, Marelli L, Kerry A, Nair D, Patch D, Burroughs AK. MELD and gender in the waiting list for liver transplantation. Transplantation 2008;85:1509-10; author reply 1510. [PMID: 18497697 DOI: 10.1097/TP.0b013e31816ff2c0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
184 Cholongitas E, Germani G, Burroughs AK. Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol. 2010;7:659-668. [PMID: 21045793 DOI: 10.1038/nrgastro.2010.169] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
185 Asghar MS, Ahsan MN, Rasheed U, Hassan M, Jawed R, Abbas MB, Yaseen R, Ali Naqvi SA, Rizvi H, Syed M. Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study. Cureus 2020;12:e12294. [PMID: 33520498 DOI: 10.7759/cureus.12294] [Reference Citation Analysis]
186 Jiang M, Liu F, Xiong WJ, Zhong L, Chen XM. Comparison of four models for end-stage liver disease in evaluating the prognosis of cirrhosis. World J Gastroenterol 2008; 14(42): 6546-6550 [PMID: 19030210 DOI: 10.3748/wjg.14.6546] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
187 Zhang XP, Wang K, Gao YZ, Wei XB, Lu CD, Chai ZT, Zhen ZJ, Li J, Yang DH, Zhou D, Fan RF, Yan ML, Xia YJ, Liu B, Huang YQ, Zhang F, Hu YR, Zhong CQ, Lin JH, Fang KP, Cheng ZH, Wu MC, Lau WY, Cheng SQ; Chinese National Research Cooperative Group for Diagnosis and Treatment of Hepatocellular Carcinoma with Tumour Thrombus. Prognostic model for identifying candidates for hepatectomy among patients with hepatocellular carcinoma and hepatic vein invasion. Br J Surg 2020;107:865-77. [PMID: 32246475 DOI: 10.1002/bjs.11524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
188 Nam JY, Choe AR, Sinn DH, Lee JH, Kim HY, Yu SJ, Kim YJ, Yoon JH, Lee JM, Chung JW, Choi SY, Lee JK, Baek SY, Lee HA, Kim TH, Yoo K. A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function. BMC Cancer 2020;20:504. [PMID: 32487089 DOI: 10.1186/s12885-020-06975-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
189 Klammt S, Mitzner SR, Stange J, Loock J, Heemann U, Emmrich J, Reisinger EC, Schmidt R. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transpl. 2008;14:1333-1339. [PMID: 18756471 DOI: 10.1002/lt.21504] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
190 Ma XL, Zhou JY, Gao XH, Tian L, Wu J, Zhang CY, Zhou Y, Dai Q, Wang BL, Pan BS, Yang XR, Guo W. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma. Clin Chim Acta. 2016;462:15-22. [PMID: 27520748 DOI: 10.1016/j.cca.2016.08.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
191 Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 2009; 15(3): 280-288 [PMID: 19140227 DOI: 10.3748/wjg.15.280] [Cited by in CrossRef: 196] [Cited by in F6Publishing: 180] [Article Influence: 15.1] [Reference Citation Analysis]
192 Chen HY, Hsu YC. Afebrile Bacteremia in Adult Emergency Department Patients with Liver Cirrhosis: Clinical Characteristics and Outcomes. Sci Rep 2020;10:7617. [PMID: 32376846 DOI: 10.1038/s41598-020-64644-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
193 Stonington SD. On ethical locations: The good death in Thailand, where ethics sit in places. Social Science & Medicine 2012;75:836-44. [DOI: 10.1016/j.socscimed.2012.03.045] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
194 Mattos ÂZ, Mattos AA, Sacco FK, Hoppe L, Oliveira DM. Analysis of the survival of cirrhotic patients enlisted for liver transplantation in the pre- and post-MELD era in southern Brazil. Arq Gastroenterol 2014;51:46-52. [PMID: 24760064 DOI: 10.1590/s0004-28032014000100010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
195 Nishikawa T, Bell A, Brooks JM, Setoyama K, Melis M, Han B, Fukumitsu K, Handa K, Tian J, Kaestner KH, Vodovotz Y, Locker J, Soto-Gutierrez A, Fox IJ. Resetting the transcription factor network reverses terminal chronic hepatic failure. J Clin Invest 2015;125:1533-44. [PMID: 25774505 DOI: 10.1172/JCI73137] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
196 Costa BP, Castro Sousa F, Serôdio M, Carvalho C. Value of MELD and MELD-Based Indices in Surgical Risk Evaluation of Cirrhotic Patients: Retrospective Analysis of 190 Cases. World J Surg 2009;33:1711-9. [DOI: 10.1007/s00268-009-0093-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
197 Mohamed YI, Lee S, Xiao L, Hassan MM, Qayyum A, Hiatia R, Pestana RC, Haque A, George B, Rashid A, Duda DG, Elghazaly H, Wolff RA, Morris JS, Yao J, Amin HM, Kaseb AO. Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib. Oncotarget 2021;12:756-66. [PMID: 33889299 DOI: 10.18632/oncotarget.27924] [Reference Citation Analysis]
198 Duan BW, Lu SC, Wu JS, Guo QL, Zeng DB, Jiang T, Kong DG, Ding J. Model for End-Stage Liver Disease (MELD) score does not predict outcomes of hepatitis B-induced acute-on-chronic liver failure in transplant recipients. Transplant Proc. 2014;46:3502-3506. [PMID: 25498080 DOI: 10.1016/j.transproceed.2014.07.075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
199 Ramachandran TM, Rajneesh AHR, Zacharia GS, Adarsh RP. Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo? J Clin Diagn Res 2017;11:OC01-5. [PMID: 29207749 DOI: 10.7860/JCDR/2017/30705.10529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
200 García Buey L, González Mateos F, Moreno-otero R. Cirrosis hepática. Medicine - Programa de Formación Médica Continuada Acreditado 2012;11:625-33. [DOI: 10.1016/s0304-5412(12)70359-1] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
201 Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-szalmas P. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. Journal of Hepatology 2013;59:457-66. [DOI: 10.1016/j.jhep.2013.04.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
202 Guo X, Xiong L, Yu L, Li R, Wang Z, Ren B, Dong J, Li B, Wang D. Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy. Diagn Pathol 2014;9:175. [PMID: 25230759 DOI: 10.1186/s13000-014-0175-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
203 Huo TI, Lin HC, Lee SD. Model for end-stage liver disease and organ allocation in liver transplantation: where are we and where should we go? J Chin Med Assoc. 2006;69:193-198. [PMID: 16835979 DOI: 10.1016/S1726-4901(09)70217-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
204 Anand AC. Nutrition and Muscle in Cirrhosis. J Clin Exp Hepatol. 2017;7:340-357. [PMID: 29234200 DOI: 10.1016/j.jceh.2017.11.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
205 Shi JY, Sun LY, Quan B, Xing H, Li C, Liang L, Pawlik TM, Zhou YH, Wang H, Gu WM, Chen TH, Lau WY, Shen F, Wang NY, Yang T. A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2021;45:101534. [PMID: 33067168 DOI: 10.1016/j.clinre.2020.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
206 Heinzow HS, Lenz P, Köhler M, Reinecke F, Ullerich H, Domschke W, Domagk D, Meister T. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis. World J Gastroenterol 2012; 18(37): 5211-5218 [PMID: 23066315 DOI: 10.3748/wjg.v18.i37.5211] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
207 Giannoni C, Chelazzi C, Villa G, De Gaudio AR. Organ dysfunction scores in ICU. Trends in Anaesthesia and Critical Care 2013;3:89-96. [DOI: 10.1016/j.tacc.2013.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
208 Piñero F, Tanno M, Aballay Soteras G, Tisi Baña M, Dirchwolf M, Fassio E, Ruf A, Mengarelli S, Borzi S, Fernández N, Ridruejo E, Descalzi V, Anders M, Mazzolini G, Reggiardo V, Marciano S, Perazzo F, Spina JC, McCormack L, Maraschio M, Lagues C, Gadano A, Villamil F, Silva M, Cairo F, Ameigeiras B; Argentinean Association for the Study of Liver Diseases (A.A.E.E.H). Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma. Ann Hepatol 2020;19:546-69. [PMID: 32593747 DOI: 10.1016/j.aohep.2020.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
209 Li JD, Diao YK, Li J, Wu H, Sun LY, Gu WM, Wang H, Chen TH, Zeng YY, Zhou YH, Wang Y, Zhang YM, Liang YJ, Lau WY, Li C, Liang L, Wang MD, Zhang CW, Shen F, Shao CH, Yang T. Association between preoperative prealbumin level and postoperative mortality and morbidity after hepatic resection for hepatocellular carcinoma: A multicenter study from a HBV-endemic area. Am J Surg 2021;221:1024-32. [PMID: 32951853 DOI: 10.1016/j.amjsurg.2020.08.036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
210 Cuomo O, Perrella A, Arenga G. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system? Transplant Proc. 2008;40:1906-1909. [PMID: 18675085 DOI: 10.1016/j.transproceed.2008.05.072] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
211 Pradhan RR, Kafle Bhandari B, Pathak R, Poudyal S, Anees S, Sharma S, Khadga P. The Assessment of Health-Related Quality of Life in Patients With Chronic Liver Disease: A Single-Center Study. Cureus 2020;12:e10727. [PMID: 33145133 DOI: 10.7759/cureus.10727] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
212 Costa D, Simbrunner B, Jachs M, Hartl L, Bauer D, Paternostro R, Schwabl P, Scheiner B, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.J Hepatol. 2021;74:819-828. [PMID: 33075344 DOI: 10.1016/j.jhep.2020.10.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
213 Okonkwo E, Rozario N, Heffner AC. Presentation and outcomes of end stage liver disease patients presenting with septic shock to the emergency department. Am J Emerg Med 2020;38:1408-13. [PMID: 31839522 DOI: 10.1016/j.ajem.2019.11.039] [Reference Citation Analysis]
214 Zhang Y, Xi H, Nie X, Zhang P, Lan N, Lu Y, Liu J, Yuan W. Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases. Curr Drug Metab 2019;20:785-98. [PMID: 31608838 DOI: 10.2174/1389200220666191011120434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
215 Raveh Y, Livingstone J, Mahan J, Tekin A, Selvaggi G, Bowdon‐romero M, Nicolau‐raducu R. Comprehensive Frailty Severity Index for End‐Stage Liver Disease Predicts Early Outcomes After Liver Transplantation. Journal of Parenteral and Enteral Nutrition 2020;44:1079-88. [DOI: 10.1002/jpen.1729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
216 Kaseb AO, Morris JS, Hassan MM, Siddiqui AM, Lin E, Xiao L, Abdalla EK, Vauthey JN, Aloia TA, Krishnan S, Abbruzzese JL. Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol 2011;29:3892-9. [PMID: 21911725 DOI: 10.1200/JCO.2011.36.0636] [Cited by in Crossref: 83] [Cited by in F6Publishing: 54] [Article Influence: 7.5] [Reference Citation Analysis]
217 Cai W, Zheng B, Lin X, Wu W, Chen C. Prediction of Patient Hepatic Encephalopathy Risk with Freiburg Index of Post-TIPS Survival Score Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Study. IJGM 2022;Volume 15:4007-16. [DOI: 10.2147/ijgm.s359918] [Reference Citation Analysis]
218 Wu J, Wu Q, Wu M, Mao W. Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis. Biomed Res Int 2019;2019:7272045. [PMID: 30949507 DOI: 10.1155/2019/7272045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
219 Li H, Li J, Wang J, Liu H, Cai B, Wang G, Wu H. Assessment of Liver Function for Evaluation of Long-Term Outcomes of Intrahepatic Cholangiocarcinoma: A Multi-Institutional Analysis of 620 Patients. Front Oncol 2020;10:525. [PMID: 32411593 DOI: 10.3389/fonc.2020.00525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
220 Kim Y, Kim K, Jang I. Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study. Medicine (Baltimore) 2019;98:e17862. [PMID: 31702650 DOI: 10.1097/MD.0000000000017862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Abdel-Wahab R, Shehata S, Hassan MM, Xiao L, Lee JS, Cheung S, Essa HH, Hassabo HM, Shalaby AS, Mosad E, Raghav K, Rashid A, Wolff RA, Morris JS, Amin HM, Kaseb AO. Validation of an IGF-CTP scoring system for assessing hepatic reserve in Egyptian patients with hepatocellular carcinoma. Oncotarget 2015;6:21193-207. [PMID: 26098859 DOI: 10.18632/oncotarget.4176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
222 Yang YY, Hsu YC. Effectiveness of sepsis bundle application and outcomes predictors to cirrhotic patients with septic shock. BMC Infect Dis 2021;21:483. [PMID: 34039297 DOI: 10.1186/s12879-021-06194-5] [Reference Citation Analysis]
223 Chan HL, Chim AM, Lau JT, Hui AY, Wong VW, Sung JJ. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B. Am J Gastroenterol. 2006;101:1516-1523. [PMID: 16863555 DOI: 10.1111/j.1572-0241.2006.00659.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
224 Zhao Y, Qin H, Wu Y, Xiang B. Enhanced recovery after surgery program reduces length of hospital stay and complications in liver resection: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2017;96:e7628. [PMID: 28767578 DOI: 10.1097/MD.0000000000007628] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 5.2] [Reference Citation Analysis]
225 Karie-Guigues S, Janus N, Saliba F, Dumortier J, Duvoux C, Calmus Y, Lorho R, Deray G, Launay-Vacher V, Pageaux GP. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study. Liver Transpl. 2009;15:1083-1091. [PMID: 19718632 DOI: 10.1002/lt.21803] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
226 Zhang B, Cai W, Gao F, Lin X, Qian T, Gu K, Song B, Chen T. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study. Med Sci Monit 2022;28:e934057. [PMID: 35031594 DOI: 10.12659/MSM.934057] [Reference Citation Analysis]
227 Ryu E, Kim K, Cho MS, Kwon IG, Kim HS, Fu MR. Symptom Clusters and Quality of Life in Korean Patients With Hepatocellular Carcinoma. Cancer Nursing 2010;33:3-10. [DOI: 10.1097/ncc.0b013e3181b4367e] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
228 Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis. J Gastroenterol Hepatol. 2009;24:1547-1553. [PMID: 19686416 DOI: 10.1111/j.1440-1746.2009.05913.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
229 Sasikala M, Surya P, Radhika G, Kumar PP, Rao MS, Mukherjee RM, Rao PN, Reddy DN. Identification of circulating CD90+ CD73+ cells in cirrhosis of liver. World J Stem Cells 2011; 3(7): 63-69 [PMID: 21860671 DOI: 10.4252/wjsc.v3.i7.63] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
230 Abbas M, Abbas Z. Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D. World J Hepatol 2017; 9(22): 967-972 [PMID: 28839517 DOI: 10.4254/wjh.v9.i22.967] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
231 Teng D, Zuo H, Liu L, Dong J, Ding L. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment. Virol J. 2018;15:151. [PMID: 30285813 DOI: 10.1186/s12985-018-1067-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
232 Song C, Lewis S, Kamath A, Hectors S, Putra J, Kihira S, Bane O, Ahmad J, Babb J, Thung S, Taouli B. Primary sclerosing cholangitis: diagnostic performance of MRI compared to blood tests and clinical scoring systems for the evaluation of histopathological severity of disease. Abdom Radiol (NY) 2020;45:354-64. [PMID: 31844914 DOI: 10.1007/s00261-019-02366-9] [Reference Citation Analysis]
233 Cardoso FS, Pereira R, Laranjo A, Gamelas V, Bagulho L, Germano N, Karvellas CJ. Positive fluid balance was associated with mortality in patients with acute-on-chronic liver failure: A cohort study. J Crit Care 2021;63:238-42. [PMID: 32988683 DOI: 10.1016/j.jcrc.2020.09.012] [Reference Citation Analysis]
234 Shih JL, Keating JH, Freeman LM, Webster CR. Chronic Hepatitis in Labrador Retrievers: Clinical Presentation and Prognostic Factors. Journal of Veterinary Internal Medicine 2007;21:33-9. [DOI: 10.1111/j.1939-1676.2007.tb02925.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
235 Guo X, Yang M, Gu H, Zhao J, Zou L. Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma. Cancer Epidemiol. 2013;37:732-736. [PMID: 23731550 DOI: 10.1016/j.canep.2013.05.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
236 Rai R, Nagral S, Nagral A. Surgery in a patient with liver disease. J Clin Exp Hepatol. 2012;2:238-246. [PMID: 25755440 DOI: 10.1016/j.jceh.2012.05.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
237 Gonzalo P, Pecquet M, Bon C, Gonzalo S, Radenne S, Augustin-Normand C, Souquet JC. Clinical performance of the carbohydrate-deficient transferrin (CDT) assay by the Sebia Capillarys2 system in case of cirrhosis. Interest of the Bio-Rad %CDT by HPLC test and Siemens N-Latex CDT kit as putative confirmatory methods. Clin Chim Acta 2012;413:712-8. [PMID: 22244929 DOI: 10.1016/j.cca.2011.12.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
238 Freitas M, Xavier S, Magalhães R, Magalhães J, Marinho C, Cotter J. LIRER score - a valuable tool to predict medium-long-term outcomes in hepatic cirrhosis decompensation. Scand J Gastroenterol 2020;55:1079-86. [PMID: 32715829 DOI: 10.1080/00365521.2020.1797156] [Reference Citation Analysis]
239 Grancini V, Resi V, Palmieri E, Pugliese G, Orsi E. Management of diabetes mellitus in patients undergoing liver transplantation. Pharmacol Res. 2019;141:556-573. [PMID: 30690071 DOI: 10.1016/j.phrs.2019.01.042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
240 Hughes LT, Raftery D, Coulter P, Laird B, Fallon M. Use of opioids in patients with cancer with hepatic impairment-a systematic review. BMJ Support Palliat Care 2021:bmjspcare-2021-003065. [PMID: 34470772 DOI: 10.1136/bmjspcare-2021-003065] [Reference Citation Analysis]
241 Boursier J, Cesbron E, Tropet AL, Pilette C. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients. J Clin Gastroenterol 2009;43:580-5. [PMID: 19197195 DOI: 10.1097/MCG.0b013e3181889468] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
242 Mai R, Lu H, Bai T, Liang R, Lin Y, Ma L, Xiang B, Wu G, Li L, Ye J. Artificial neural network model for preoperative prediction of severe liver failure after hemihepatectomy in patients with hepatocellular carcinoma. Surgery 2020;168:643-52. [DOI: 10.1016/j.surg.2020.06.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
243 Abolghasemi J, Eshraghian MR, Nasiri Toosi M, Mahmoodi M, Rahimi Foroushani A. Introducing an optimal liver allocation system for liver cirrhosis patients. Hepat Mon 2013;13:e10479. [PMID: 24098306 DOI: 10.5812/hepatmon.10479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
244 Rao B H, Nair P, Koshy AK, Krishnapriya S, Greeshma CR, Venu RP. Role of High-Density Lipoprotein Cholesterol (HDL-C) as a Clinical Predictor of Decompensation in Patients with Chronic Liver Disease (CLD). Int J Hepatol 2021;2021:1795851. [PMID: 34976412 DOI: 10.1155/2021/1795851] [Reference Citation Analysis]
245 Durand F, Roux O, Weiss E, Francoz C. Acute-on-chronic liver failure: Where do we stand? Liver Int 2021;41 Suppl 1:128-36. [PMID: 34155793 DOI: 10.1111/liv.14855] [Reference Citation Analysis]
246 Huang HC, Chen MY, Hsieh LW, Chiu HY, Miao NF, Wu CS, Lin KC. Validation of a Symptoms Distress Scale in a Cirrhotic Population Using Item Response Theory. Nurs Res 2018;67:359-68. [PMID: 30160660 DOI: 10.1097/NNR.0000000000000296] [Reference Citation Analysis]
247 Oliveira Coberllini Jacques R, Silva Massignan L, Schumacher Winkler M, Sartori Balbinot R, Balbinot RA, Sartori Balbinot S, Soldera J. Liver‐specific scores as predictors of mortality in spontaneous bacterial peritonitis. GastroHep 2020;2:224-31. [DOI: 10.1002/ygh2.419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
248 Öcal O, Peynircioglu B, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Iezzi R, Benito A, Schütte K, Gasbarrini A, Seidensticker R, Wildgruber M, Pech M, Malfertheiner P, Ricke J, Seidensticker M. Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial. Eur Radiol 2021. [PMID: 34467453 DOI: 10.1007/s00330-021-08218-9] [Reference Citation Analysis]
249 Hung CC, Hsu YC, Lin KH. Comparing Mortality Risk Predictive Ability of Different Scoring Systems in Cirrhotic Patients with Bacteremia. Emerg Med Int 2020;2020:8596567. [PMID: 33163235 DOI: 10.1155/2020/8596567] [Reference Citation Analysis]
250 Peng Y, Qi X, Guo X. Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore) 2016;95:e2877. [PMID: 26937922 DOI: 10.1097/MD.0000000000002877] [Cited by in Crossref: 187] [Cited by in F6Publishing: 111] [Article Influence: 31.2] [Reference Citation Analysis]
251 Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl. 2006;12:1049-1061. [PMID: 16799946 DOI: 10.1002/lt.20824] [Cited by in Crossref: 204] [Cited by in F6Publishing: 182] [Article Influence: 12.8] [Reference Citation Analysis]
252 Klammt S, Mitzner S, Stange J, Brinkmann B, Drewelow B, Emmrich J, Liebe S, Schmidt R. Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease: . European Journal of Gastroenterology & Hepatology 2007;19:257-63. [DOI: 10.1097/meg.0b013e3280101f7d] [Cited by in Crossref: 43] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
253 Kanbayashi Y, Hatano Y, Hata Y, Morita T, Fukui K, Hosokawa T. Predictive factors for agitation severity of hyperactive delirium in terminally ill cancer patients in a general hospital using ordered logistic regression analysis. J Palliat Med 2013;16:1020-5. [PMID: 23888304 DOI: 10.1089/jpm.2013.0100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
254 Zhang J, Liu X, Ye B, Chen H. Ammonia predicts poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure. J Clin Lab Anal 2020;34:e23553. [PMID: 32914901 DOI: 10.1002/jcla.23553] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
255 Rowe I, Neuberger J. Prognostic models in cirrhosis: an aid but not a replacement for clinical judgement. Liver Int 2007;27:595-7. [DOI: 10.1111/j.1478-3231.2007.01476.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
256 Bowen SR, Chapman TR, Borgman J, Miyaoka RS, Kinahan PE, Liou IW, Sandison GA, Vesselle HJ, Nyflot MJ, Apisarnthanarax S. Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients. EJNMMI Res. 2016;6:57. [PMID: 27349530 DOI: 10.1186/s13550-016-0212-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
257 Mocan T, Kang DW, Molloy BJ, Jeon H, Spârchez ZA, Beyoğlu D, Idle JR. Plasma fetal bile acids 7α-hydroxy-3-oxochol-4-en-24-oic acid and 3-oxachola-4,6-dien-24-oic acid indicate severity of liver cirrhosis. Sci Rep 2021;11:8298. [PMID: 33859329 DOI: 10.1038/s41598-021-87921-5] [Reference Citation Analysis]
258 Roy MJ, Erdman KA, Abeyratne AT, Plumb LC, Lasseter K, Riff DS, Keirns JJ. Pharmacokinetics of intravenous conivaptan in subjects with hepatic or renal impairment. Clin Pharmacokinet 2013;52:385-95. [PMID: 23456393 DOI: 10.1007/s40262-013-0047-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
259 Ye L, Liang R, Zhang J, Chen C, Chen X, Zhang Y, Wang G, Yang Y, Chen G. Postoperative albumin-bilirubin grade and albumin-bilirubin change predict the outcomes of hepatocellular carcinoma after hepatectomy. Ann Transl Med. 2019;7:367. [PMID: 31555681 DOI: 10.21037/atm.2019.06.01] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
260 Dillon A, Galvin Z, Sultan AA, Harman D, Guha IN, Stewart S. Transient elastography can stratify patients with Child–Pugh A cirrhosis according to risk of early decompensation. European Journal of Gastroenterology & Hepatology 2018;30:1434-40. [DOI: 10.1097/meg.0000000000001224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Chan AWH, Chong CCN, Mo FKF, Wong J, Yeo W, Johnson PJ, Yu S, Lai PBS, Chan ATC, To K, Chan SL. Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma: Albumin-bilirubin-based Italian staging. Journal of Gastroenterology and Hepatology 2017;32:221-8. [DOI: 10.1111/jgh.13457] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
262 Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis. J Clin Gastroenterol. 2007;41:706-712. [PMID: 17667056 DOI: 10.1097/mcg.0b013e31802dabb3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
263 Tacke F, Fiedler K, Trautwein C. A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease. Scand J Gastroenterol. 2007;42:374-382. [PMID: 17354118 DOI: 10.1080/00365520600930826] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
264 Suárez-Dono J, Cervantes-Pérez E, Pena-Seijo M, Formigo-Couceiro F, Ferrón-Vidán F, Novo-Veleiro I, Del Corral-Beamonte E, Díez-Manglano J, Gude-Sampedro F, Pose-Reino A. CRONIGAL: Prognostic index for chronic patients after hospital admission. Eur J Intern Med 2016;36:25-31. [PMID: 27745854 DOI: 10.1016/j.ejim.2016.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
265 Huo T, Lin H, Huang Y, Wu J, Chiang J, Lee P, Lee S. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer 2006;107:141-8. [DOI: 10.1002/cncr.21972] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
266 Hassan EA, Abd El-Rehim AS. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience. Arab J Gastroenterol 2013;14:158-64. [PMID: 24433645 DOI: 10.1016/j.ajg.2013.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
267 Chen XL, Chen TW, Zhang XM, Li ZL, Zeng NL, Zhou P, Li H, Ren J, Xu GH, Hu JN. Platelet count combined with right liver volume and spleen volume measured by magnetic resonance imaging for identifying cirrhosis and esophageal varices. World J Gastroenterol 2015; 21(35): 10184-10191 [PMID: 26401083 DOI: 10.3748/wjg.v21.i35.10184] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
268 Oikonomou T, Goulis L, Doumtsis P, Tzoumari T, Akriviadis E, Cholongitas E. ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis. Ann Hepatol. 2019;18:126-136. [PMID: 31113581 DOI: 10.5604/01.3001.0012.7904] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
269 Wang MC, Lin WH, Tseng CC, Wu AB, Teng CH, Yan JJ, Wu JJ. Role of K1 capsule antigen in cirrhotic patients with Escherichia coli spontaneous bacterial peritonitis in southern Taiwan. Eur J Clin Microbiol Infect Dis. 2013;32:407-412. [PMID: 23052990 DOI: 10.1007/s10096-012-1757-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
270 Lavekar A, Raje D, Sadar A, Manohar T, Manjari KS, Satyanarayana PT. Predictors of Three-month Hospital Readmissions and Mortality in Patients with Cirrhosis of Liver. Euroasian J Hepatogastroenterol 2019;9:71-7. [PMID: 32117694 DOI: 10.5005/jp-journals-10018-1302] [Reference Citation Analysis]
271 Huang F, Gao J. Modified Child-Pugh grade vs albumin-bilirubin grade for predicting prognosis of hepatocellular carcinoma patients after hepatectomy. World J Gastroenterol 2020; 26(7): 749-758 [PMID: 32116422 DOI: 10.3748/wjg.v26.i7.749] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
272 Gómez Selgas A, Bexfield N, Scase TJ, Holmes MA, Watson P. Total serum bilirubin as a negative prognostic factor in idiopathic canine chronic hepatitis. J Vet Diagn Invest 2014;26:246-51. [PMID: 24621844 DOI: 10.1177/1040638713520602] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
273 Lee DH, Lee JH, Jung YJ, Gim J, Kim W, Kim BG, Lee KL, Cho Y, Yoo JJ, Lee M, Cho YY, Cho EJ, Yu SJ, Kim YJ, Yoon JH. Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area. PLoS One 2017;12:e0170394. [PMID: 28107416 DOI: 10.1371/journal.pone.0170394] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
274 Salgüero S, Medrano LM, González-García J, Berenguer J, Montes ML, Diéz C, Garcia-Broncano P, Llop-Herrera E, Pérez-Latorre L, Bellóno JM, Jiménez-Sousa MÁ, Resino S. Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study. Sci Rep 2020;10:10384. [PMID: 32587340 DOI: 10.1038/s41598-020-67159-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
275 Chen W, You J, Chen J, Zheng Q, Jiang JJ, Zhu YY. Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2017; 23(40): 7303-7309 [PMID: 29142477 DOI: 10.3748/wjg.v23.i40.7303] [Reference Citation Analysis]
276 Papp M, Norman GL, Vitalis Z, Tornai I, Altorjay I, Foldi I, Udvardy M, Shums Z, Dinya T, Orosz P. Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity? PLoS One. 2010;5:e12957. [PMID: 20886039 DOI: 10.1371/journal.pone.0012957] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
277 García-compean D, Jaquez-quintana JO, Maldonado-garza H. Hepatogenous diabetes. Current views of an ancient problem. Annals of Hepatology 2009;8:13-20. [DOI: 10.1016/s1665-2681(19)31805-8] [Cited by in Crossref: 59] [Article Influence: 4.5] [Reference Citation Analysis]
278 El-Ghannam MT, Hassanien MH, El-Talkawy MD, Saleem AAA, Sabry AI, Abu Taleb HM. Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases. J Clin Diagn Res 2017;11:OC12-6. [PMID: 28764217 DOI: 10.7860/JCDR/2017/24543.9980] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
279 Trapani S, Morabito V, Oliveti A, Peritore D, Rizzo A, Cacciotti A, Gaeta A, Montemurro A, Rizzato L, Nanni Costa A. Liver Allocation in Urgent MELD Score ≥30: The Italian Experience. Transplantation Proceedings 2016;48:299-303. [DOI: 10.1016/j.transproceed.2015.12.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
280 Mai RY, Ye JZ, Long ZR, Shi XM, Bai T, Chen J, Li LQ, Wu GB, Wu FX. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res. 2019;11:1401-1414. [PMID: 30863151 DOI: 10.2147/cmar.s186114] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
281 Lim CH, Moon SH, Cho YS, Choi JY, Lee K, Hyun SH. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with combined hepatocellular-cholangiocarcinoma. Eur J Nucl Med Mol Imaging 2019;46:1705-12. [DOI: 10.1007/s00259-019-04327-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
282 Wang YY, Zhao XH, Ma L, Ye JZ, Wu FX, Tang J, You XM, Xiang BD, Li LQ. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma. J Surg Oncol. 2018;118:440-445. [PMID: 30259515 DOI: 10.1002/jso.25184] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
283 Chin KM, Koh YX, Syn N, Teo JY, Goh BKP, Cheow PC, Chung YFA, Ooi LL, Chan CY, Lee SY. Early Prediction of Post-hepatectomy Liver Failure in Patients Undergoing Major Hepatectomy Using a PHLF Prognostic Nomogram. World J Surg 2020;44:4197-206. [PMID: 32860142 DOI: 10.1007/s00268-020-05713-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
284 Sersté T, Melot C, Francoz C, Durand F, Rautou P, Valla D, Moreau R, Lebrec D. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 2010;52:1017-22. [DOI: 10.1002/hep.23775] [Cited by in Crossref: 329] [Cited by in F6Publishing: 247] [Article Influence: 27.4] [Reference Citation Analysis]
285 Lin X, Gao F, Wu X, Cai W, Chen X, Huang Z. Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol 2021;33:862-71. [PMID: 32541240 DOI: 10.1097/MEG.0000000000001801] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
286 Hamed AE, Elsahar M, Elwan NM, El-Nakeep S, Naguib M, Soliman HH, Aboubakr AA, AbdelMaqsod A, Sedrak H, Assaad SN, Elwakil R, Esmat G, Salh S, Mostafa T, Mogawer S, Sadek SE, Saber MM, Ezelarab H, Mahmoud AA, Sultan S, El Kassas M, Kamal E, ElSayed NM, Moussa S; Jury, Reviewers and Advisory Board: Sherif Abdelfattah, Samir Helmy ASSAAD-KHALIL, Ahmed Ali Elgarem, Rawia Khater, Amr Helmi, Hisham Elborlsy, Abdelhamid Attia (President of the Arab Federation Of Evidence-Based Medicine). Managing diabetes and liver disease association: Practice guidelines from the Egyptian Association for the Study of Liver and Gastrointestinal Disease (EASLGD). Arab J Gastroenterol 2019;20:61-3. [PMID: 30852101 DOI: 10.1016/j.ajg.2019.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
287 Robertson M, Lim AKH, Bloom A, Chung W, Tsoi A, Cannan E, Johnstone B, Huynh A, O'Halloran T, Gow P, Angus P, Jones D. Epidemiology and Prognostic Significance of Rapid Response System Activation in Patients Undergoing Liver Transplantation. J Clin Med 2021;10:5680. [PMID: 34884382 DOI: 10.3390/jcm10235680] [Reference Citation Analysis]
288 Papp M, Tornai T, Vitalis Z, Tornai I, Tornai D, Dinya T, Sumegi A, Antal-Szalmas P. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis. World J Gastroenterol 2016; 22(41): 9172-9185 [PMID: 27895404 DOI: 10.3748/wjg.v22.i41.9172] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
289 Hunold P, Berg T, Seehofer D, Sucher R, Herber A, Isermann B, Thiery J, Kaiser T. Experiences from six years of quality assured Model of End Stage Liver Disease (MELD) diagnostics. PLoS One 2021;16:e0254219. [PMID: 34437537 DOI: 10.1371/journal.pone.0254219] [Reference Citation Analysis]
290 Gabr RM, El Salmawy DA, Basheer MA, Khairy M, Elkholy SH. Relation between the severity of liver cirrhosis and neurological symptoms, nerve conduction study results, and motor unit number estimation. J Viral Hepat 2021;28:1312-8. [PMID: 34048134 DOI: 10.1111/jvh.13552] [Reference Citation Analysis]
291 De Fina B, Nasser F, Cavalcante RN, Campos CA, Galastri FL, Affonso BB, Wolosker N, Perin MA. Safety and Effectiveness of Suture-mediated Arterial Closure Device in Hepatocellular Carcinoma Patients Who Underwent Drug-Eluting Beads Transarterial Chemoembolization. Ann Vasc Surg 2019;55:203-9. [PMID: 30217703 DOI: 10.1016/j.avsg.2018.05.077] [Reference Citation Analysis]
292 Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2006;22:254-262. [PMID: 16550040 DOI: 10.1097/01.mog.0000218962.93806.9a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
293 Periyalwar P, Dasarathy S. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis. 2012;16:95-131. [PMID: 22321468 DOI: 10.1016/j.cld.2011.12.009] [Cited by in Crossref: 132] [Cited by in F6Publishing: 117] [Article Influence: 13.2] [Reference Citation Analysis]
294 Horsmans Y, Hu K, Ruffin M, Wang Y, Song D, Bouillaud E, Wang Y, Mazur D, Botha F, Heuman DM. Effect of Hepatic Impairment on the Pharmacokinetics of Pasireotide (SOM230): Results From a Multicenter Phase I Study. The Journal of Clinical Pharmacology 2012;52:552-8. [DOI: 10.1177/0091270011400072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
295 Fan W, Liao W, Luo Y, You B, Yu J, Li C. Clinical prediction for outcomes of patients with acute-on-chronic liver failure associated with HBV infection: A new model establishment. Open Med (Wars) 2020;15:714-22. [PMID: 33336028 DOI: 10.1515/med-2020-0207] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
296 Shao YY, Liu TH, Lee YH, Hsu CH, Cheng AL. Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2016;31:1336-41. [PMID: 26860846 DOI: 10.1111/jgh.13312] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
297 Durand F. Risk scores in cirrhotic patients: From non-transplant surgery to transplantation and back. J Hepatol 2006;44:620-1. [PMID: 16427720 DOI: 10.1016/j.jhep.2005.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
298 Silveira F, Silveira FP, Macri MM, Nicoluzzi JE. [Analysis of liver waiting list mortality in Paraná, Brazi: what shall we do to face organ shortage?]. Arq Bras Cir Dig 2012;25:110-3. [PMID: 23381754 DOI: 10.1590/s0102-67202012000200010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
299 Muilenburg DJ, Singh A, Torzilli G, Khatri VP. Surgery in the patient with liver disease. Anesthesiol Clin 2009;27:721-37. [PMID: 19942176 DOI: 10.1016/j.anclin.2009.09.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
300 D'Amico G. Developing concepts on MELD: delta and cutoffs. J Hepatol 2005;42:790-2. [PMID: 15885348 DOI: 10.1016/j.jhep.2005.03.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
301 Nie Y, Wan S, Zhang Y, Liu C, Zhu X. Serum Urea Predicts Long-term Mortality in Hospitalized Patients with Decompensated Cirrhosis. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.99497] [Reference Citation Analysis]
302 Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology 2017;93:233-42. [PMID: 28683459 DOI: 10.1159/000455957] [Reference Citation Analysis]
303 Neskovic N, Mandic D, Marczi S, Skiljic S, Kristek G, Vinkovic H, Mraovic B, Debeljak Z, Kvolik S. Different Pharmacokinetics of Tramadol, O-Demethyltramadol and N-Demethyltramadol in Postoperative Surgical Patients From Those Observed in Medical Patients. Front Pharmacol 2021;12:656748. [PMID: 33935773 DOI: 10.3389/fphar.2021.656748] [Reference Citation Analysis]
304 Salgado AA, Barbosa PRB, Ferreira AG, Reis CASS, Terra C. Prognostic Value of a New Marker of Ventricular Repolarization in Cirrhotic Patients. Arq Bras Cardiol 2016;107:523-31. [PMID: 28558079 DOI: 10.5935/abc.20160181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
305 Zhang T, Zeng Y, Huang J, Liao M, Wu H. Combined resection with radiofrequency ablation for bilobar hepatocellular carcinoma: a single-center experience. Journal of Surgical Research 2014;191:370-8. [DOI: 10.1016/j.jss.2014.03.048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
306 Faria SC, Szklaruk J, Kaseb AO, Hassabo HM, Elsayes KM. TNM/Okuda/Barcelona/UNOS/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: concepts, perspectives, and radiologic implications. Abdom Imaging. 2014;39:1070-1087. [PMID: 24695938 DOI: 10.1007/s00261-014-0130-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
307 Kim HJ, Lee HW. Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol. 2013;19:105-115. [PMID: 23837134 DOI: 10.3350/cmh.2013.19.2.105] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
308 Amaral AED, Rode MP, Cisilotto J, Silva TED, Fischer J, Matiollo C, Morais Rateke EC, Narciso-Schiavon JL, Schiavon LL, Creczynski-Pasa TB. MicroRNA profiles in serum samples from patients with stable cirrhosis and miRNA-21 as a predictor of transplant-free survival. Pharmacol Res 2018;134:179-92. [PMID: 29935272 DOI: 10.1016/j.phrs.2018.06.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
309 Jiang Y, Qin S, Wei X, Liu X, Guan J, Zhu H, Chang G, Chen Y, Lu H, Qian J, Wang Z, Shen M, Lin X. Highly activated TRAIL+ CD56bright NK cells are associated with the liver damage in HBV-LC patients. Immunol Lett 2021;232:9-19. [PMID: 33515618 DOI: 10.1016/j.imlet.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
310 Cai W, Lin H, Qi R, Lin X, Zhao Y, Chen W, Huang Z. Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year. Cardiovasc Intervent Radiol 2021. [PMID: 34523022 DOI: 10.1007/s00270-021-02961-8] [Reference Citation Analysis]
311 Papp M, Vitalis Z, Altorjay I, Tornai I, Udvardy M, Harsfalvi J, Vida A, Kappelmayer J, Lakatos PL, Antal-Szalmas P. Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections. Liver Int. 2012;32:603-611. [PMID: 22145664 DOI: 10.1111/j.1478-3231.2011.02689.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
312 Liu Q, Li F, Zhuang Y, Xu J, Wang J, Mao X, Zhang Y, Liu X. Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma. Gut Pathog. 2019;11:1. [PMID: 30675188 DOI: 10.1186/s13099-018-0281-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
313 Teixeira A, Souza F, Sankarankutty A, Martinelli A, Castro e Silva O. Characteristics of Waitlisted Patients for Liver Transplantation at a Liver Transplantation Unit in the City of Ribeirão Preto, São Paulo, Brazil, Especially Considering Child and Model for End Stage Liver Disease (MELD) Scores. Transplantation Proceedings 2007;39:387-9. [DOI: 10.1016/j.transproceed.2007.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
314 Chan AW, Chan RC, Wong GL, Wong VW, Choi PC, Chan HL, To KF. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score. J Gastroenterol Hepatol. 2015;30:1391-1396. [PMID: 25753927 DOI: 10.1111/jgh.12938] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 9.8] [Reference Citation Analysis]
315 Ginès P, Fernández J, Durand F, Saliba F. Management of critically-ill cirrhotic patients. J Hepatol. 2012;56 Suppl 1:S13-S24. [PMID: 22300462 DOI: 10.1016/s0168-8278(12)60003-8] [Cited by in Crossref: 86] [Cited by in F6Publishing: 27] [Article Influence: 8.6] [Reference Citation Analysis]